ProCE Banner Activity

CROI 2022: Long-Acting ART in Western Europe

Clinical Thought
Self-administered long-acting antiretroviral therapy will empower people with HIV and enhance patient privacy, but there may be trade-offs.

Released: March 10, 2022

Expiration: March 09, 2023

Share

Faculty

José R. Arribas

José R. Arribas, MD

Professor of Medicine
Department of Medicine
Autónoma University School of Medicine
Head, Infectious Diseases Unit
Department of Internal Medicine
Hospital La Paz
Madrid, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Cepheid

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

José R. Arribas, MD

Professor of Medicine
Department of Medicine
Autónoma University School of Medicine
Head, Infectious Diseases Unit
Department of Internal Medicine
Hospital La Paz
Madrid, Spain

José R. Arribas, MD, has disclosed that he has received consulting fees from Aelix, Janssen, MSD, Serono, and ViiV; funds for research support from Gilead Sciences and ViiV; and fees for non-CME/CE services from Gilead Sciences.